Intelligence Hub
Market analytics and operational performance indicators
Insider Trading - December 16, 2025
CEO Beck's trust sold 2,500,000 shares ($141M) via 10b5-1 plan.
Brief
Rocket Lab CEO Peter Beck's family trust executed multiple sales totaling 2.5 million shares on Dec 15-16, 2025, pursuant to a Rule 10b5-1 trading plan adopted in June 2025. The transactions liquidated the trust's holdings to zero, with shares sold at weighted average prices ranging from $53.21 to $64.31. This is a neutral signal as it is a pre-scheduled, non-discretionary sale.
Detailed Brief
Peter Beck, CEO and Director of Rocket Lab USA Inc. (RKLB), reported sales of 2,500,000 common shares held indirectly by his family trust (Equatorial Trust) across multiple tranches on December 15 and 16, 2025. The sales occurred automatically under a Rule 10b5-1 trading plan established on June 13, 2025, with weighted average prices per tranche ranging from $55.64 on 12/15 to $56.00 on 12/16 final tranche, and some higher up to $64.31 early on 12/15 before prices dipped on 12/16. Total proceeds approximate $141 million. Post-transaction, the trust holds 0 shares, while Beck retains 902,942 shares directly. No derivative transactions reported. This appears to be a one-time liquidation of trust holdings via pre-planned sales, with no indication of recent prior similar activity mentioned; neutral pattern as 10b5-1 removes insider discretion.
Key Telemetry
- • Sold 2,500,000 shares (100% of trust holdings, ~73% of Beck's total prior ~3.4M shares) for ~$141M.
- • Executed under 10b5-1 plan adopted June 13, 2025 (6 months prior).
- • Prices ranged $53-$64, near recent highs before dip on 12/16.
- • Retains 902,942 shares directly post-sale.
- • Neutral context: pre-planned liquidation, no cluster or discretionary element.
Risk Signals
Impact Vector
This large 10b5-1 sale by CEO Beck's family trust signals neutral insider confidence, as pre-established plans mitigate concerns over timing or discretion, often used for estate planning, diversification, or liquidity without implying reduced faith in the company.